Furthermore, there are additional pathways involved in the resistance to BRAF inhibitors in BRAF-mutated CRC cells and, among others, the PI3K/AKT signaling pathway and the crosstalk between Wnt and MAPK pathways [79,80]. Here, BRAF is linked to colorectal carcinoma.